Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
September 25, 2024 08:55 ET
|
Kronos Bio, Inc.
– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory...
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
September 25, 2024 08:45 ET
|
GRI Bio, Inc.
Live video webcast on Wednesday, October 2nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a...
Del Taco Continues to Expand Presence Throughout Florida With 13th Location Opening Soon
September 25, 2024 08:45 ET
|
Del Taco
KISSIMMEE, Fla., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Del Taco, the nation’s second-largest Mexican quick service restaurant*, announced the opening of the newest location at 7531 W. Irlo Bronson...
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
September 25, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
September 25, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies based on a...
Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
September 25, 2024 08:30 ET
|
Sonnet BioTherapeutics Holdings, Inc.
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted...
Byrna Technologies to Report Fiscal Third Quarter 2024 Financial Results on Wednesday, October 9, 2024 at 9:00 a.m. ET
September 25, 2024 08:30 ET
|
Byrna Technologies, Inc.
ANDOVER, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development,...
Data Storage Corporation Secures Expanded Contract Servicing a Billion Dollar Insurance Company
September 25, 2024 08:30 ET
|
Data Storage Corp.
MELVILLE, N.Y., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud...
HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
September 25, 2024 08:30 ET
|
HeartCore Enterprises Inc.
NEW YORK and TOKYO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company...
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
September 25, 2024 08:30 ET
|
Entera Bio Ltd.; OPKO Health, Inc.
JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development of orally delivered peptides, and OPKO Health, Inc. (NASDAQ: OPK) (OPKO)...